A detailed history of Bell Investment Advisors, Inc transactions in Argenx Se stock. As of the latest transaction made, Bell Investment Advisors, Inc holds 5 shares of ARGX stock, worth $3,141. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5
Previous 5 -0.0%
Holding current value
$3,141
Previous $2,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$356.01 - $451.55 $712 - $903
-2 Reduced 28.57%
5 $2,000
Q1 2024

May 08, 2024

BUY
$356.95 - $413.29 $1,070 - $1,239
3 Added 75.0%
7 $2,000
Q4 2023

Feb 14, 2024

BUY
$338.91 - $506.01 $338 - $506
1 Added 33.33%
4 $1,000
Q1 2023

May 10, 2023

SELL
$334.23 - $403.65 $4,679 - $5,651
-14 Reduced 82.35%
3 $1,000
Q4 2022

Feb 08, 2023

BUY
$342.17 - $402.31 $342 - $402
1 Added 6.25%
17 $6,000
Q3 2022

Nov 09, 2022

BUY
$343.2 - $395.75 $4,804 - $5,540
14 Added 700.0%
16 $6,000
Q2 2022

Aug 12, 2022

BUY
$269.58 - $378.88 $539 - $757
2 New
2 $1,000

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $34.8B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Bell Investment Advisors, Inc Portfolio

Follow Bell Investment Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bell Investment Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bell Investment Advisors, Inc with notifications on news.